Acadia Healthcare (NASDAQ:ACHC) Trading 7.4% Higher – Should You Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shot up 7.4% during trading on Wednesday . The company traded as high as $32.87 and last traded at $32.0820. Approximately 194,755 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 3,182,073 shares. The stock had previously closed at $29.87.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. TD Cowen raised their target price on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Barclays lifted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. KeyCorp upped their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Stock Down 1.2%

The company has a market capitalization of $2.81 billion, a P/E ratio of -2.43, a P/E/G ratio of 9.85 and a beta of 0.64. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm has a fifty day simple moving average of $30.39 and a 200-day simple moving average of $26.04.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same quarter in the previous year, the business posted $0.83 EPS. Acadia Healthcare’s revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ACHC. Clough Capital Partners L P acquired a new position in shares of Acadia Healthcare during the first quarter worth about $5,359,000. Deutsche Bank AG bought a new stake in Acadia Healthcare in the 2nd quarter valued at approximately $49,746,000. Lisanti Capital Growth LLC bought a new stake in Acadia Healthcare in the 2nd quarter valued at approximately $4,502,000. Bank of America Corp DE grew its stake in shares of Acadia Healthcare by 64.7% during the 1st quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock worth $28,797,000 after acquiring an additional 483,649 shares in the last quarter. Finally, Royal Bank of Canada raised its holdings in shares of Acadia Healthcare by 7,896.1% in the first quarter. Royal Bank of Canada now owns 278,265 shares of the company’s stock valued at $6,508,000 after purchasing an additional 274,785 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.